Predictive Models for Human Organ Toxicity Based on <i>In Vitro</i> Bioactivity Data and Chemical Structure
Tuan Xu(University of Chinese Academy of Sciences), Ruili Huang(National Institutes of Health), Anton Simeonov(National Institutes of Health), Lin Ye(Beijing Institute of Technology), Bin Zhao(Northwestern Polytechnical University), Deborah K. Ngan(National Institutes of Health), Heidi Q. Xie(Hong Kong University of Science and Technology), Menghang Xia(National Center for Advancing Translational Sciences)
Cited by 40
Related Papers
Exactly the Same but Different: Promiscuity and Diversity in the Molecular Mechanisms of Action of the Aryl Hydrocarbon (Dioxin) Receptor
|Toxicological Sciences|2011|753
Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|391
<i>In Vitro</i> Biologic Activities of the Antimicrobials Triclocarban, Its Analogs, and Triclosan in Bioassay Screens: Receptor-Based Bioassay Screens
|Environmental Health Perspectives|2008|349
Erratum: Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|327
CH223191 Is a Ligand-Selective Antagonist of the Ah (Dioxin) Receptor
|Toxicological Sciences|2010|314